PHAR Stock | | | USD 7.53 0.23 2.96% |
Pharming Group financial indicator trend analysis is much more than just breaking down Pharming Group NV prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Pharming Group NV is a good investment. Please check the relationship between Pharming Group Long Term Debt and its Total Liab accounts. Check out
Your Equity Center to better understand how to build diversified portfolios, which includes a position in Pharming Group NV. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in nation.
Long Term Debt vs Total Liab
Long Term Debt vs Total Liab Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of
Pharming Group NV Long Term Debt account and
Total Liab. At this time, the significance of the direction appears to have strong relationship.
The correlation between Pharming Group's Long Term Debt and Total Liab is 0.61. Overlapping area represents the amount of variation of Long Term Debt that can explain the historical movement of Total Liab in the same time period over historical financial statements of Pharming Group NV, assuming nothing else is changed. The correlation between historical values of Pharming Group's Long Term Debt and Total Liab is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Long Term Debt of Pharming Group NV are associated (or correlated) with its Total Liab. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Total Liab has no effect on the direction of Long Term Debt i.e., Pharming Group's Long Term Debt and Total Liab go up and down completely randomly.
Correlation Coefficient | 0.61 |
Relationship Direction | Positive |
Relationship Strength | Significant |
Long Term Debt
Long-term debt is a debt that Pharming Group NV has held for over one year. Long-term debt appears on Pharming Group NV balance sheet and also includes long-term leases. The most common forms of long term debt are bonds payable, long-term notes payable, mortgage payable, pension liabilities, and lease liabilities. In the corporate world, long-term debt is generally used to fund big-ticket items, such as machinery, buildings, and land. The total of long-term debt reported on Pharming Group NV balance sheet is the sum of the balances of all categories of long-term debt. Debt that is not due within the current year and is often considered to be financing activities that are to be repaid over several years.
Total Liab
The total amount of all liabilities that a company has, including both short-term and long-term liabilities.
Most indicators from Pharming Group's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Pharming Group NV current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out
Your Equity Center to better understand how to build diversified portfolios, which includes a position in Pharming Group NV. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in nation.
At this time, Pharming Group's
Selling General Administrative is relatively stable compared to the past year. As of 11/22/2024,
Issuance Of Capital Stock is likely to grow to about 4
M, while
Tax Provision is likely to drop (1.5
M).
Pharming Group fundamental ratios Correlations
Click cells to compare fundamentals
Pharming Group Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Pharming Group fundamental ratios Accounts
Additional Tools for Pharming Stock Analysis
When running Pharming Group's price analysis, check to
measure Pharming Group's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pharming Group is operating at the current time. Most of Pharming Group's value examination focuses on studying past and present price action to
predict the probability of Pharming Group's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pharming Group's price. Additionally, you may evaluate how the addition of Pharming Group to your portfolios can decrease your overall portfolio volatility.